Zimmer Biomet Holdings (ZBH) 116.69 $ZBH
Zimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss
PR Newswire - Thu Jun 16, 3:30PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the global commercial launch of new enhancements to its OSS(TM) Orthopedic Salvage System, a comprehensive set of joint reconstruction prostheses designed to treat patients suffering from bone loss due to tumor resection, ligamentous deficiencies, orthopaedic trauma or patients who have undergone multiple knee and hip revision arthroplasties.
ZBH: 116.69 (-4.23)
LDR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of LDR Holding Corporation (LDRH) Over the Proposed Sale of the Company to Zimmer Biomet Holdings, Inc.
PR Newswire - Wed Jun 15, 10:18AM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of LDR Holding Corporation ("LDR" or the "Company"
(NASDAQ:LDRH) for potential breaches of fiduciary duties in connection with the sale of the Company to Zimmer Biomet Holdings, Inc. for approximately $1.0 billion.
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
PR Newswire - Thu Jun 09, 10:20AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Is $37.00 a Fair Price?
PR Newswire - Wed Jun 08, 7:14PM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 22.37 (-0.60), ICUI: 106.49 (-1.64), ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
ACCESSWIRE - Tue Jun 07, 10:19AM CDT
NEW YORK, NY / ACCESSWIRE / June 7, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
LDR HOLDING CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Tue Jun 07, 9:28AM CDT
Rigrodsky & Long, P.A.:
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
Zimmer buying LDR for $1 billion
AP - Tue Jun 07, 8:04AM CDT
NEW YORK (AP) — Zimmer Biomet will spend $1 billion to acquire medical device maker buy LDR Holding Corp., strengthening its position in the spine disorder surgical technology business.
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Are Shareholders Getting a Fair Price?
PR Newswire - Tue Jun 07, 7:13AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
Zimmer Biomet to Acquire LDR to Enhance Innovation and Growth of Spine Business
GlobeNewswire - Tue Jun 07, 6:05AM CDT
-- Significantly Expands Portfolio of Innovative Solutions for $10 Billion Spine Market
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
Zimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine Business
PR Newswire - Tue Jun 07, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (Zimmer Biomet or the Company), a global leader in musculoskeletal healthcare, and LDR Holding Corporation (NASDAQ: LDRH) (LDR), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that both Boards of Directors have approved a definitive agreement under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares of LDR for $37.00 per share in cash, which implies a transaction value of approximately $1.0 billion. The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2016.
ZMH: 113.56 (+0.29), ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
How are These Healthcare Stocks Faring? - Zimmer Biomet, Wright Medical, Spectranetics and Prestige Brands
PR Newswire - Fri Jun 03, 7:00AM CDT
In today's pre-market coverage, ActiveWallSt.com has these four Medical Appliances and Equipment stocks lined up for investors to review: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Wright Medical Group N.V. (NASDAQ: WMGI), The Spectranetics Corp. (NASDAQ: SPNC), and Prestige Brands Holdings Inc. (NYSE: PBH). Register now to access these stocks' trade alerts by clicking on the following link:
SPNC: 17.92 (-0.48), ZBH: 116.69 (-4.23), WMGI: 16.66 (-0.97), PBH: 53.15 (-1.36), WMGIZ: 1.25 (unch)
Zimmer Biomet: Strong Q1, Integration Synergy Continues
Zacks Equity Research - Zacks Investment Research - Mon May 23, 6:39AM CDT
On May 23, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 22.37 (-0.60), ICUI: 106.49 (-1.64), ZBH: 116.69 (-4.23), NUVA: 57.93 (-0.93)
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2016
PR Newswire - Mon May 23, 6:30AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2016.
ZBH: 116.69 (-4.23)
Global Spine Implants Market 2016 - Forecasts To 2022 - The US Leads the Way - Research and Markets
PR Newswire Europe - Fri May 20, 12:11PM CDT
Research and Markets has announced the addition of the "Spine Implants Global Market - Forecast To 2022" [http://www.researchandmarkets.com/research/zbr323/spine_implants] report to their offering.
JNJ: 115.63 (-1.75), ZBH: 116.69 (-4.23), MDT: 83.26 (-2.51), GMED: 23.85 (-0.06), KTWO: 15.05 (-0.61)
Zimmer Biomet Completes Acquisition of Cayenne Medical
PR Newswire - Mon May 16, 6:30AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today the completion of its previously announced acquisition of Scottsdale, Arizona-based Cayenne Medical, Inc. Cayenne Medical designs, develops and markets technically advanced soft tissue repair and reconstruction solutions for the knee, shoulder and extremities.
ZMH: 113.56 (+0.29), ZBH: 116.69 (-4.23)
Dental Implant and Prosthetics Market - 5.35% CAGR Forecast to 2021
PR Newswire Europe - Wed May 11, 1:01AM CDT
PUNE, India, May 11, 2016 /PRNewswire/ --
ZBH: 116.69 (-4.23), DHR: 98.21 (-2.23)
Zimmer Biomet Holdings to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
PR Newswire - Tue May 03, 3:01PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be presenting at the Bank of America Merrill Lynch 2016 Health Care Conference at the Encore Wynn hotel in Las Vegas, Nevada on Wednesday, May 11, at 8 a.m. Pacific Time.
ZBH: 116.69 (-4.23)
Zimmer Biomet (ZBH) Beats on Q1 Earnings, Margins Drag
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:51AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) reported first-quarter 2016 adjusted earnings per share (EPS) of $2.00, up 29.9% year over year.
BSX: 22.37 (-0.60), CAPR: 4.18 (-0.20), ZBH: 116.69 (-4.23), BAX: 43.85 (-2.11)
Zimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss
PR Newswire - Thu Jun 16, 3:30PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the global commercial launch of new enhancements to its OSS(TM) Orthopedic Salvage System, a comprehensive set of joint reconstruction prostheses designed to treat patients suffering from bone loss due to tumor resection, ligamentous deficiencies, orthopaedic trauma or patients who have undergone multiple knee and hip revision arthroplasties.
ZBH: 116.69 (-4.23)
LDR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of LDR Holding Corporation (LDRH) Over the Proposed Sale of the Company to Zimmer Biomet Holdings, Inc.
PR Newswire - Wed Jun 15, 10:18AM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of LDR Holding Corporation ("LDR" or the "Company"
(NASDAQ:LDRH) for potential breaches of fiduciary duties in connection with the sale of the Company to Zimmer Biomet Holdings, Inc. for approximately $1.0 billion. ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
PR Newswire - Thu Jun 09, 10:20AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Is $37.00 a Fair Price?
PR Newswire - Wed Jun 08, 7:14PM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
Zimmer Biomet's Spine Business to Get a Boost with LDR Buy
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) has entered into a definitive agreement to acquire LDR Holding Corp. (LDRH) for a total deal value of $1 billion.
BSX: 22.37 (-0.60), ICUI: 106.49 (-1.64), ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH
ACCESSWIRE - Tue Jun 07, 10:19AM CDT
NEW YORK, NY / ACCESSWIRE / June 7, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
LDR HOLDING CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Tue Jun 07, 9:28AM CDT
Rigrodsky & Long, P.A.:
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
Zimmer buying LDR for $1 billion
AP - Tue Jun 07, 8:04AM CDT
NEW YORK (AP) — Zimmer Biomet will spend $1 billion to acquire medical device maker buy LDR Holding Corp., strengthening its position in the spine disorder surgical technology business.
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
LDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Are Shareholders Getting a Fair Price?
PR Newswire - Tue Jun 07, 7:13AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached their fiduciary duties in connection with the proposed sale of the Company to Zimmer Biomet Holdings, Inc. (NYSE: ZBH).
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
Zimmer Biomet to Acquire LDR to Enhance Innovation and Growth of Spine Business
GlobeNewswire - Tue Jun 07, 6:05AM CDT
-- Significantly Expands Portfolio of Innovative Solutions for $10 Billion Spine Market
ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
Zimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine Business
PR Newswire - Tue Jun 07, 6:00AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (Zimmer Biomet or the Company), a global leader in musculoskeletal healthcare, and LDR Holding Corporation (NASDAQ: LDRH) (LDR), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that both Boards of Directors have approved a definitive agreement under which Zimmer Biomet will commence a tender offer to acquire all of the outstanding shares of LDR for $37.00 per share in cash, which implies a transaction value of approximately $1.0 billion. The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2016.
ZMH: 113.56 (+0.29), ZBH: 116.69 (-4.23), LDRH: 37.03 (unch)
How are These Healthcare Stocks Faring? - Zimmer Biomet, Wright Medical, Spectranetics and Prestige Brands
PR Newswire - Fri Jun 03, 7:00AM CDT
In today's pre-market coverage, ActiveWallSt.com has these four Medical Appliances and Equipment stocks lined up for investors to review: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Wright Medical Group N.V. (NASDAQ: WMGI), The Spectranetics Corp. (NASDAQ: SPNC), and Prestige Brands Holdings Inc. (NYSE: PBH). Register now to access these stocks' trade alerts by clicking on the following link:
SPNC: 17.92 (-0.48), ZBH: 116.69 (-4.23), WMGI: 16.66 (-0.97), PBH: 53.15 (-1.36), WMGIZ: 1.25 (unch)
Zimmer Biomet: Strong Q1, Integration Synergy Continues
Zacks Equity Research - Zacks Investment Research - Mon May 23, 6:39AM CDT
On May 23, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 22.37 (-0.60), ICUI: 106.49 (-1.64), ZBH: 116.69 (-4.23), NUVA: 57.93 (-0.93)
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2016
PR Newswire - Mon May 23, 6:30AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2016.
ZBH: 116.69 (-4.23)
Global Spine Implants Market 2016 - Forecasts To 2022 - The US Leads the Way - Research and Markets
PR Newswire Europe - Fri May 20, 12:11PM CDT
Research and Markets has announced the addition of the "Spine Implants Global Market - Forecast To 2022" [http://www.researchandmarkets.com/research/zbr323/spine_implants] report to their offering.
JNJ: 115.63 (-1.75), ZBH: 116.69 (-4.23), MDT: 83.26 (-2.51), GMED: 23.85 (-0.06), KTWO: 15.05 (-0.61)
Zimmer Biomet Completes Acquisition of Cayenne Medical
PR Newswire - Mon May 16, 6:30AM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today the completion of its previously announced acquisition of Scottsdale, Arizona-based Cayenne Medical, Inc. Cayenne Medical designs, develops and markets technically advanced soft tissue repair and reconstruction solutions for the knee, shoulder and extremities.
ZMH: 113.56 (+0.29), ZBH: 116.69 (-4.23)
Dental Implant and Prosthetics Market - 5.35% CAGR Forecast to 2021
PR Newswire Europe - Wed May 11, 1:01AM CDT
PUNE, India, May 11, 2016 /PRNewswire/ --
ZBH: 116.69 (-4.23), DHR: 98.21 (-2.23)
Zimmer Biomet Holdings to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
PR Newswire - Tue May 03, 3:01PM CDT
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be presenting at the Bank of America Merrill Lynch 2016 Health Care Conference at the Encore Wynn hotel in Las Vegas, Nevada on Wednesday, May 11, at 8 a.m. Pacific Time.
ZBH: 116.69 (-4.23)
Zimmer Biomet (ZBH) Beats on Q1 Earnings, Margins Drag
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:51AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) reported first-quarter 2016 adjusted earnings per share (EPS) of $2.00, up 29.9% year over year.
BSX: 22.37 (-0.60), CAPR: 4.18 (-0.20), ZBH: 116.69 (-4.23), BAX: 43.85 (-2.11)
